MedTrace Logo

Ultra-brief Intervention for Problem Drinkers

NCT00688584 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1767

Last updated 2013-04-09

No results posted yet for this study

Summary

The major objective of this proposal is to conduct a randomized controlled trial of an ultra-brief, personalized feedback intervention (a pamphlet) for problem drinkers. Subjects will be recruited via a telephone survey which will collect baseline data. The households of half of the subjects will receive the pamphlet as unaddressed ad mail shortly thereafter. Follow-up interviews will be conducted, by telephone, three and six months after the mailing of the pamphlets.

Hypothesis 1: Respondents from households who receive the pamphlet will display significantly improved drinking outcomes at the three-month and six-month follow-ups as compared to respondents from households in the no intervention control condition.

Hypothesis 2: More calls will be received on a help-line listed on the pamphlet (and advertised elsewhere) from residents of households who receive the pamphlet as compared to residents from households who do not receive the pamphlet.

Hypotheses 3 - 6 deal with mediator and moderator hypotheses, exploring the role of perceived risk, perceived drinking norms, and drinking for social reasons.

Conditions

  • Problem Drinking
  • Alcoholism

Interventions

BEHAVIORAL

Pamphlet-based personalized alcohol feedback (PAF)

participants in this condition will be mailed their respective pamphlets

BEHAVIORAL

control pamphlet condition

The goal is to test if it is the specific content of the pamphlet that leads to the change or just the receipt of any pamphlet.

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • Centre for Addiction and Mental Health

    lead OTHER

Principal Investigators

  • John Cunningham, PhD · Centre for Addiction and Mental Health

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-12-31
Primary Completion
2010-12-31
Completion
2010-12-31

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00688584 on ClinicalTrials.gov